Indiana AG Todd Rokita touts 'monumental victory' in Sackler family, Purdue opioid settlement
Indiana will receive up to $100 million to support addiction recovery programs as part of the largest settlement to date holding suppliers accountable for their role in the opioid crisis, according to Indiana Attorney General Todd Rokita.
In all, $7.4 billion will be dispersed to dozens of states and territories across the U.S. The Sackler family and Purdue Pharma were ordered to pay for "aggressive marketing of opioid products" that "fueled the worst drug crisis in U.S. history," Rokita said.
Rokita called the settlement a "monumental victory" for Hoosiers. In Marion County, fentanyl kills more people than homicides and car crashes combined.
Drug addiction in Indiana: What a grieving mother's story shows us about the fentanyl crisis in Indianapolis
In 2020, Purdue Pharma admitted to paying doctors to encourage them to prescribe more opioids and impeding the U.S. Drug Enforcement Administration's effort to fight the burgeoning epidemic. The settlement also permanently ends the Sackler family's control of Purdue Pharma, according to the Attorney General's office, and prohibits them from participating in the U.S. opioid industry.
Indiana's funds will be released over the next 15 years. Most will be dispersed in the first three years.
"This is about accountability and justice," said Rokita.
A Marion County program that alerts recipients about bad drug batches or overdose spikes can be accessed by texting SOAR to 765-358-7627.
If you or a loved one is struggling with mental health or substance abuse problems, contact the Substance Abuse and Mental Health Services Administration at 1-800-662-HELP (4357) for help.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
4 hours ago
- Miami Herald
In U.S. opioid crisis, states say yes to $7B Purdue Pharma settlement
June 16 (UPI) -- All 50 states, the District of Columbia and four other U.S. territories signed off on a multi-billion dollar settlement proposal with OxyContin maker Purdue Pharma in litigation over Purdue's alleged role in fueling America's opioid addiction crisis. In March, Purdue Pharma attorneys filed the proposed $7.4 billion settlement deal in a federal bankruptcy court over Purdue's assumed role in improper marketing practices after private negotiations with state attorneys general and other stakeholders in its bid to finalize the years-long lawsuit. It takes the place of a prior settlement proposal the U.S Supreme Court overturned last year in a 5-4 ruling in June. If finalized by all relevant parties, payouts would be issued over the next several years contingent on the approval by a U.S. bankruptcy court. Purdue first introduced its oxycodone spinoff into the U.S. market in the 1990s, but in 2019 filed for Chapter 11 bankruptcy protections after Perdue was later recipient to thousands of lawsuits over OxyContin. State law enforcement officers in California, Colorado, Connecticut, Delaware, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia and West Virginia lead settlement talks in what is now thought to be America's largest lawsuit of its caliber involving the opioid addiction epidemic. Purdue under the ownership of the Sackler family invented, manufactured and marketed its opioid products for decades, which local officials say directly exasperated addiction and droves of overdose-related deaths. The settlement ends Sackler family control of Purdue Pharma, bars their ability to sell opioids in the United States with the Sacklers expected to pay $6.5 billion. Purdue Pharma, to be overseen by a monitor, must shell out nearly $900 million in its first payment, followed by $500 million a year later then again after two years, and $400 million after three years. In a statement, Perdue said Monday's revelation of "unanimous support" for the settlement among states and territories was a "critical milestone towards confirming a Plan of Reorganization that will provide billions of dollars to compensate victims, abate the opioid crisis and deliver opioid use disorder and overdose rescue medicines that will save American lives." It will infuse more than $50 billion by corporate America over the next 15 years in hard-hit small towns where addiction flourished in order to support programming for opioid addiction treatment, prevention and recovery. "We appreciate the extraordinarily hard work of the state attorneys general and our other creditors in getting us to this point, and we look forward to soliciting creditor votes on the Plan after the disclosure statement is approved," Purdue officials added. On Monday, Pennsylvania's attorney general noted how the state's local communities and its families "suffered" in what he described as an "unprecedented addiction crisis" in which Purdue and its Sacklers "reaped the mammoth profits from their products." "This monumental settlement achieves the top priority of getting as much money as quickly as possible to prevention, treatment and recovery programs across the Commonwealth," Sunday, a Republican, wrote in a statement. Meanwhile, local governments will be asked to join states in approving the settlement as part of legal process. A court hearing is schedule for Wednesday on the matter. Copyright 2025 UPI News Corporation. All Rights Reserved.
UPI
4 hours ago
- UPI
In U.S. opioid crisis, states say yes to $7B Purdue Pharma settlement
June 16 (UPI) -- All 50 states, the District of Columbia and four other U.S. territories signed off on a multi-billion dollar settlement proposal with OxyContin maker Purdue Pharma in litigation over Purdue's alleged role in fueling America's opioid addiction crisis. In March, Purdue Pharma attorneys filed the proposed $7.4 billion settlement deal in a federal bankruptcy court over Purdue's assumed role in improper marketing practices after private negotiations with state attorneys general and other stakeholders in its bid to finalize the years-long lawsuit. It takes the place of a prior settlement proposal the U.S Supreme Court overturned last year in a 5-4 ruling in June. If finalized by all relevant parties, payouts would be issued over the next several years contingent on the approval by a U.S. bankruptcy court. Purdue first introduced its oxycodone spinoff into the U.S. market in the 1990s, but in 2019 filed for Chapter 11 bankruptcy protections after Perdue was later recipient to thousands of lawsuits over OxyContin. State law enforcement officers in California, Colorado, Connecticut, Delaware, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia and West Virginia lead settlement talks in what is now thought to be America's largest lawsuit of its caliber involving the opioid addiction epidemic. Purdue under the ownership of the Sackler family invented, manufactured and marketed its opioid products for decades, which local officials say directly exasperated addiction and droves of overdose-related deaths. The settlement ends Sackler family control of Purdue Pharma, bars their ability to sell opioids in the United States with the Sacklers expected to pay $6.5 billion. Purdue Pharma, to be overseen by a monitor, must shell out nearly $900 million in its first payment, followed by $500 million a year later then again after two years, and $400 million after three years. In a statement, Perdue said Monday's revelation of "unanimous support" for the settlement among states and territories was a "critical milestone towards confirming a Plan of Reorganization that will provide billions of dollars to compensate victims, abate the opioid crisis and deliver opioid use disorder and overdose rescue medicines that will save American lives." It will infuse more than $50 billion by corporate America over the next 15 years in hard-hit small towns where addiction flourished in order to support programming for opioid addiction treatment, prevention and recovery. "We appreciate the extraordinarily hard work of the state attorneys general and our other creditors in getting us to this point, and we look forward to soliciting creditor votes on the Plan after the disclosure statement is approved," Purdue officials added. On Monday, Pennsylvania's attorney general noted how the state's local communities and its families "suffered" in what he described as an "unprecedented addiction crisis" in which Purdue and its Sacklers "reaped the mammoth profits from their products." "This monumental settlement achieves the top priority of getting as much money as quickly as possible to prevention, treatment and recovery programs across the Commonwealth," Sunday, a Republican, wrote in a statement. Meanwhile, local governments will be asked to join states in approving the settlement as part of legal process. A court hearing is schedule for Wednesday on the matter.
Indianapolis Star
9 hours ago
- Indianapolis Star
Indiana AG Todd Rokita touts 'monumental victory' in Sackler family, Purdue opioid settlement
Indiana will receive up to $100 million to support addiction recovery programs as part of the largest settlement to date holding suppliers accountable for their role in the opioid crisis, according to Indiana Attorney General Todd Rokita. In all, $7.4 billion will be dispersed to dozens of states and territories across the U.S. The Sackler family and Purdue Pharma were ordered to pay for "aggressive marketing of opioid products" that "fueled the worst drug crisis in U.S. history," Rokita said. Rokita called the settlement a "monumental victory" for Hoosiers. In Marion County, fentanyl kills more people than homicides and car crashes combined. Drug addiction in Indiana: What a grieving mother's story shows us about the fentanyl crisis in Indianapolis In 2020, Purdue Pharma admitted to paying doctors to encourage them to prescribe more opioids and impeding the U.S. Drug Enforcement Administration's effort to fight the burgeoning epidemic. The settlement also permanently ends the Sackler family's control of Purdue Pharma, according to the Attorney General's office, and prohibits them from participating in the U.S. opioid industry. Indiana's funds will be released over the next 15 years. Most will be dispersed in the first three years. "This is about accountability and justice," said Rokita. A Marion County program that alerts recipients about bad drug batches or overdose spikes can be accessed by texting SOAR to 765-358-7627. If you or a loved one is struggling with mental health or substance abuse problems, contact the Substance Abuse and Mental Health Services Administration at 1-800-662-HELP (4357) for help.
